Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie

Warsaw 02-781

0 studies enrolling now · 6 studies all time

What they study most

Advanced Cholangiocarcinoma, Advanced Non-Small Cell Lung Cancer, Breast Cancer, Castration-resistant Prostate Cancer, Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement, Giant Cell Tumors of the Tendon Sheath, Pigmented Villonodular Synovitis, Prostate Cancer Metastatic, Tenosynovial Giant Cell Tumor

Studies at this site

• Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement — Recruiting now
• Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma — Running, not enrolling
• Study With Various Immunotherapy Treatments in Participants With Lung Cancer — Running, not enrolling
• ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer — Completed
• Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS) — Completed
• Trial of Myocet in Metastatic Breast Cancer — Status unconfirmed